Showing results (191-200 of 630) with videos related to
Sort By:
Pageof 63
Seminars in Arthritis and Rheumatism|February 24, 2020
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritisCorrado Campochiaro, Alessandro Tomelleri, Silvia Sartorelli, et al.Ophthalmology|September 24, 2019
Different Factors Associated with 2-Year Outcomes in Patients with Branch versus Central Retinal Vein Occlusion Treated with RanibizumabRaafay Sophie, Pin-Wen Wang, Roomasa Channa, et al.Frontiers in Medicine|February 8, 2024
Periostin expression in uninvolved skin as a potential biomarker for rapid cutaneous progression in systemic sclerosis patients: a preliminary explorative studyGiacomo De Luca, Corrado Campochiaro, Samuele E Burastero, et al.Frontiers in Immunology|June 19, 2018
Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester DiseaseAlessandro Tomelleri, Giulio Cavalli, Giacomo De Luca, et al.Scandinavian Journal of Rheumatology|May 9, 2019
Gender differences in clinical presentation and vascular pattern in patients with Takayasu arteritisA Tomelleri, C Campochiaro, S Sartorelli, et al.American Journal of Rhinology & Allergy|March 18, 2015
Nasal mucosa narrow band imaging in granulomatosis with polyangiitis (Wegener granulomatosis): A preliminary studyMatteo Trimarchi, Enrica Bozzolo, Francesco Pilolli, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 1990
Localization of blood-retinal barrier breakdown in human pathologic specimens by immunohistochemical staining for albuminS A Vinores, P A Campochiaro, A Lee, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|April 17, 1999
Histopathological features of vitreous removed at macular hole surgeryS R Sadda, P A Campochiaro, E de Juan, et al.Ophthalmology|January 14, 2017
Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic RetinopathyCharles C Wykoff, Usha Chakravarthy, Peter A Campochiaro, et al.Molecular Pharmacology|March 11, 2006
Suppression and regression of choroidal neovascularization by systemic administration of an alpha5beta1 integrin antagonistNaoyasu Umeda, Shu Kachi, Hideo Akiyama, et al.Pageof 63